MapLight Therapeutics, Inc. Common Stock Share Price
NASDAQ: MPLT
Live MapLight Therapeutics, Inc. Common Stock Share Price Chart
O H L
MapLight Therapeutics, Inc. Common Stock Performance Overview
Days Range
▼
$10.95Low
$11.10High
Markets Today
| Previous Close | $11.32 |
|---|---|
| Open | $11.00 |
| Volume | 133,652 |
| Day's Range | $10.95 - $11.10 |
| 52W Range | NA |
| Market Cap | $528.71 M |
Historical Performance
| 1M Returns | -4.23 |
|---|---|
| 3M Returns | -60.72 |
| 6M Returns | -33.49 |
| 1Y Returns | NA |
| 5Y Returns | NA |
| 10Y Returns | NA |
MapLight Therapeutics, Inc. Common Stock Fundamentals
| Market Cap | $528.71 M |
|---|---|
| Dividend yield | N/A |
| PE Ratio | N/A |
| PEG Ratio | N/A |
| Revenue | $0.00 |
| ROE TTM | N/A |
| EPS TTM | N/A |
| Quarterly Earnings Growth YOY | N/A |
| PB Ratio | N/A |
| EBITDA | $-168.50 M |
| Profit Margin | N/A |
| Market Cap | $528.71 M |
|---|---|
| Dividend yield | N/A |
| PE Ratio | N/A |
| PEG Ratio | N/A |
| Revenue | $0.00 |
| ROE TTM | N/A |
| EPS TTM | N/A |
|---|---|
| Quarterly Earnings Growth YOY | N/A |
| PB Ratio | N/A |
| EBITDA | $-168.50 M |
| Profit Margin | N/A |
MapLight Therapeutics, Inc. Common Stock Profit & Loss
Quarterly
| Dec 2025 | Mar 2026 | Jun 2026 | |
|---|---|---|---|
| Total Revenue + | $0 | $0 | $0 |
| Gross Profit + | $0 | $0 | $0 |
| Operating Income | -$83.38 M | -$64.50 M | -$63.55 M |
| EBITDA | -$83.24 M | -$64.34 M | -$63.40 M |
| Interest Expense | $0 | $0 | $0 |
| Depreciation | $140.00 K | $162.00 K | $147.00 K |
| Income Before Tax | -$79.55 M | -$60.67 M | -$60.19 M |
| Income Tax Expense | $0 | $0 | $0 |
| Net Income + | -$79.55 M | -$60.67 M | -$60.19 M |
| Net Profit Margin | - | - | - |
MapLight Therapeutics, Inc. Common Stock Financials Balance Sheet In USD
Quarterly
| Dec 2025 | Mar 2026 | Jun 2026 | |
|---|---|---|---|
| Share Capital | $5.00 K | $5.00 K | $5.00 K |
| Reserve & Surplus | -$360.75 M | -$422.07 M | -$482.32 M |
| Non-Current Liabilities | $4.91 M | $4.67 M | $755.00 K |
| Current Liabilities | $16.23 M | $14.28 M | $19.29 M |
| Total Liabilities | $21.14 M | $18.95 M | $20.05 M |
| Fixed Assets | $1.09 M | $968.00 K | $828.00 K |
| Current Assets | $324.67 M | $327.23 M | $318.79 M |
| Total Assets | $479.51 M | $418.79 M | $368.35 M |
MapLight Therapeutics, Inc. Common Stock Cash Flow
Quarterly
| Dec 2025 | Mar 2026 | Jun 2026 | |
|---|---|---|---|
| Net Income | -$79.55 M | -$60.67 M | -$60.19 M |
| Operating Cash Flow | -$46.83 M | -$51.18 M | -$44.87 M |
| Investing Cash Flow | -$242.55 M | $67.01 M | $60.70 M |
| Financing Cash Flow | $271.96 M | -$6.85 M | $92.00 K |
| Change in Cash | -$17.42 M | $8.98 M | $15.93 M |
MapLight Therapeutics, Inc. Common Stock Return Calculator
The MapLight Therapeutics, Inc. Common Stock stock calculator helps Indian investors calculate returns based on the historical performance of the stock. Just choose your investment amount and duration to get insights and invest more confidently. See stock returns as well as the effect of dollar appreciation over different durations.
*Dollar Impact: The bonus return you make when the US Dollar rises against the Rupee; calculated on the full amount you walk away with, not just what you invested in.
Returns Estimator
Based on past performance of this fund
ENTER AMOUNT
$10,000
Select Duration
5Yrs
1 Yr5 Yrs
If you had invested $10,000 5 years ago, what would its value be today?$10,000
Invested Amount$10,000
Est. Returns$0
About MapLight Therapeutics, Inc. Common Stock
MapLight Therapeutics Inc is a clinical-stage biopharmaceutical company focused on developing treatments for central nervous system disorders. Its discovery platform identifies neural circuits causally linked to disease and targets them for therapeutic modulation, aiming to improve efficacy, safety, tolerability, and ease of use. The company was founded by leaders in psychiatry and neuroscience research to address the lack of circuit-specific pharmacotherapies. Its product candidate, ML-007C-MA, is a fixed-dose combination of an M1/M4 muscarinic agonist and a peripherally acting anticholinergic, being developed for schizophrenia and Alzheimer's disease psychosis, designed to activate central receptors while mitigating peripheral side effects.
Popular Stocks
FAQs
What is the share price of MapLight Therapeutics, Inc. Common Stock today?
MapLight Therapeutics, Inc. Common Stock (MPLT) share price as of September 18, 2026 is $10.85. If you are investing from India, you can always check the valuation in the INR before investing.
Can Indian Investors purchase shares of MapLight Therapeutics, Inc. Common Stock?
Yes, Indian Investors can invest in the MapLight Therapeutics, Inc. Common Stock (MPLT) Share by opening an international trading account with Angel One.
How can I purchase MapLight Therapeutics, Inc. Common Stock shares in India?
Purchasing MapLight Therapeutics, Inc. Common Stock (MPLT) share from India can be done by: Directly: By opening an international trading account with Angel One. The process would include KYC verification. The account activation takes a few minutes to a few hours, after which you can start buying MapLight Therapeutics, Inc. Common Stock (MPLT) by making deposits in US dollars. Indirectly: By investing in mutual funds and Exchange Traded Funds (ETF) that offers exposure in global stocks.
Can I buy Fractional shares of MapLight Therapeutics, Inc. Common Stock?
Yes, you can purchase fractional shares of MapLight Therapeutics, Inc. Common Stock (MPLT) or any other US company shares in Angel One for any dollar amount.
What is the market capitalization value of MapLight Therapeutics, Inc. Common Stock?
The market capitalization of MapLight Therapeutics, Inc. Common Stock on September 18, 2026, is $528.71 M.
In which sector MapLight Therapeutics, Inc. Common Stock belongs?
MapLight Therapeutics, Inc. Common Stock operates in the null sector, specifically in the null industry.
What documents are required to invest in MapLight Therapeutics, Inc. Common Stock stocks?
In order to invest in MapLight Therapeutics, Inc. Common Stock (MPLT) you will need Proof of Identification (Aadhaar, PAN, Passport etc.) and Proof of Address (Aadhaar, Voter Card etc.). From start to end, the process is digital and can be seamless.
Diversify Your Portfolio with US Stocks
Invest in Wall Street Giants from India
